Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein

Julie A. Wood, Paul L. Wood, Randall Ryan, Neill R Graff Radford, Carmencita Pilapil, Yves Robitaille, Remi Quirion

Research output: Contribution to journalArticle

199 Citations (Scopus)

Abstract

Recent immunocytochemical data have demonstrated increases in interleukin-1β (IL-1β), interleukin-6 (IL-6) and the IL-6-inducible acute phase protein, α2-macroglobulin (α2-M), in Alzheimer's disease (AD) brains. We investigated the levels of these proteins quantitatively using ELISA procedures and determined if increases in IL-1β were compensated for by a parallel increase in the endogenous interleukin-1 receptor antagonist (IL-1RA). Comparing control vs. Alzheimer's temporal cortex, we examined mature IL-1β, IL-1RA, IL-6, α2-M and C-reactive protein (CRP). The specificities of the ELISA procedures were verified by serial dilutions of the samples; by chromatofocusing, and by Sephadex G-150 gel filtration. There were no differences in the levels of mature IL-1β or IL-1RA in AD and control brains. However, IL-6 levels were detectable in 14 of the 16 Alzheimer samples but only 2 of the 14 control samples. There were also significant increases seen in α2-M and CRP levels in the Alzheimer's group compared to controls. These data support previous studies demonstrating a possible up-regulation of neuroimmune function in Alzheimer's cortex; however, we cannot determine, at this time, if this immune reaction is initiated by IL-1β.

Original languageEnglish (US)
Pages (from-to)245-252
Number of pages8
JournalBrain Research
Volume629
Issue number2
DOIs
StatePublished - Dec 3 1993

Fingerprint

Macroglobulins
Interleukin-1 Receptors
Acute-Phase Proteins
Temporal Lobe
Interleukin-1
C-Reactive Protein
Interleukin-2
Interleukin-6
Cytokines
Alzheimer Disease
Enzyme-Linked Immunosorbent Assay
Brain
Gel Chromatography
Up-Regulation
Proteins

Keywords

  • Acute phase protein
  • Alzheimer's disease
  • C-reactive protein
  • Interleukin-1 receptor antagonist
  • Interleukin-1β
  • Interleukin-6
  • α2-Macroglobulin

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Cytokine indices in Alzheimer's temporal cortex : no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein. / Wood, Julie A.; Wood, Paul L.; Ryan, Randall; Graff Radford, Neill R; Pilapil, Carmencita; Robitaille, Yves; Quirion, Remi.

In: Brain Research, Vol. 629, No. 2, 03.12.1993, p. 245-252.

Research output: Contribution to journalArticle

Wood, Julie A. ; Wood, Paul L. ; Ryan, Randall ; Graff Radford, Neill R ; Pilapil, Carmencita ; Robitaille, Yves ; Quirion, Remi. / Cytokine indices in Alzheimer's temporal cortex : no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein. In: Brain Research. 1993 ; Vol. 629, No. 2. pp. 245-252.
@article{7002418146994d25ba8ef08ce1e6a2d4,
title = "Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein",
abstract = "Recent immunocytochemical data have demonstrated increases in interleukin-1β (IL-1β), interleukin-6 (IL-6) and the IL-6-inducible acute phase protein, α2-macroglobulin (α2-M), in Alzheimer's disease (AD) brains. We investigated the levels of these proteins quantitatively using ELISA procedures and determined if increases in IL-1β were compensated for by a parallel increase in the endogenous interleukin-1 receptor antagonist (IL-1RA). Comparing control vs. Alzheimer's temporal cortex, we examined mature IL-1β, IL-1RA, IL-6, α2-M and C-reactive protein (CRP). The specificities of the ELISA procedures were verified by serial dilutions of the samples; by chromatofocusing, and by Sephadex G-150 gel filtration. There were no differences in the levels of mature IL-1β or IL-1RA in AD and control brains. However, IL-6 levels were detectable in 14 of the 16 Alzheimer samples but only 2 of the 14 control samples. There were also significant increases seen in α2-M and CRP levels in the Alzheimer's group compared to controls. These data support previous studies demonstrating a possible up-regulation of neuroimmune function in Alzheimer's cortex; however, we cannot determine, at this time, if this immune reaction is initiated by IL-1β.",
keywords = "Acute phase protein, Alzheimer's disease, C-reactive protein, Interleukin-1 receptor antagonist, Interleukin-1β, Interleukin-6, α2-Macroglobulin",
author = "Wood, {Julie A.} and Wood, {Paul L.} and Randall Ryan and {Graff Radford}, {Neill R} and Carmencita Pilapil and Yves Robitaille and Remi Quirion",
year = "1993",
month = "12",
day = "3",
doi = "10.1016/0006-8993(93)91327-O",
language = "English (US)",
volume = "629",
pages = "245--252",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Cytokine indices in Alzheimer's temporal cortex

T2 - no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein

AU - Wood, Julie A.

AU - Wood, Paul L.

AU - Ryan, Randall

AU - Graff Radford, Neill R

AU - Pilapil, Carmencita

AU - Robitaille, Yves

AU - Quirion, Remi

PY - 1993/12/3

Y1 - 1993/12/3

N2 - Recent immunocytochemical data have demonstrated increases in interleukin-1β (IL-1β), interleukin-6 (IL-6) and the IL-6-inducible acute phase protein, α2-macroglobulin (α2-M), in Alzheimer's disease (AD) brains. We investigated the levels of these proteins quantitatively using ELISA procedures and determined if increases in IL-1β were compensated for by a parallel increase in the endogenous interleukin-1 receptor antagonist (IL-1RA). Comparing control vs. Alzheimer's temporal cortex, we examined mature IL-1β, IL-1RA, IL-6, α2-M and C-reactive protein (CRP). The specificities of the ELISA procedures were verified by serial dilutions of the samples; by chromatofocusing, and by Sephadex G-150 gel filtration. There were no differences in the levels of mature IL-1β or IL-1RA in AD and control brains. However, IL-6 levels were detectable in 14 of the 16 Alzheimer samples but only 2 of the 14 control samples. There were also significant increases seen in α2-M and CRP levels in the Alzheimer's group compared to controls. These data support previous studies demonstrating a possible up-regulation of neuroimmune function in Alzheimer's cortex; however, we cannot determine, at this time, if this immune reaction is initiated by IL-1β.

AB - Recent immunocytochemical data have demonstrated increases in interleukin-1β (IL-1β), interleukin-6 (IL-6) and the IL-6-inducible acute phase protein, α2-macroglobulin (α2-M), in Alzheimer's disease (AD) brains. We investigated the levels of these proteins quantitatively using ELISA procedures and determined if increases in IL-1β were compensated for by a parallel increase in the endogenous interleukin-1 receptor antagonist (IL-1RA). Comparing control vs. Alzheimer's temporal cortex, we examined mature IL-1β, IL-1RA, IL-6, α2-M and C-reactive protein (CRP). The specificities of the ELISA procedures were verified by serial dilutions of the samples; by chromatofocusing, and by Sephadex G-150 gel filtration. There were no differences in the levels of mature IL-1β or IL-1RA in AD and control brains. However, IL-6 levels were detectable in 14 of the 16 Alzheimer samples but only 2 of the 14 control samples. There were also significant increases seen in α2-M and CRP levels in the Alzheimer's group compared to controls. These data support previous studies demonstrating a possible up-regulation of neuroimmune function in Alzheimer's cortex; however, we cannot determine, at this time, if this immune reaction is initiated by IL-1β.

KW - Acute phase protein

KW - Alzheimer's disease

KW - C-reactive protein

KW - Interleukin-1 receptor antagonist

KW - Interleukin-1β

KW - Interleukin-6

KW - α2-Macroglobulin

UR - http://www.scopus.com/inward/record.url?scp=0027453380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027453380&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(93)91327-O

DO - 10.1016/0006-8993(93)91327-O

M3 - Article

C2 - 7509248

AN - SCOPUS:0027453380

VL - 629

SP - 245

EP - 252

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -